AABB's Corporate Partner Program is designed for corporate members of the blood and biotherapies community.
This unique program offers corporate entities new and innovative ways to connect with professionals in the field. It also offers the opportunity to work directly with AABB to help support education, resources and other tools that are critical for the community to grow and thrive.
Blood, biotherapies and specialized facilities throughout the world attain AABB accreditation to demonstrate a commitment to quality and safety while continuously improving operations. AABB provides accredited facilities with a well-recognized mark of uncompromising quality. Our accreditation process is based on AABB's renowned quality systems approach that helps to optimize existing processes.
AABB Global Services provides technical assistance to advance optimal quality and safety for blood and biotherapies facilities throughout the world. AABB Global Services work includes training, development of clinical guidelines and country-specific standards, and outreach to ministries of health.
AABB's Standards-Compliant Products Program benefits both vendors and customers by offering assurance that products for the blood and biotherapies community are in compliance with AABB Standards.
AABB is approved as a Third-Party Reviewer by the FDA to conduct primary review for eligible devices for the FDA 510(k) process, which is used for most medical devices to receive marketing clearance in the United States.
4550 Montgomery Avenue
Suite 700, North Tower
Bethesda, MD 20814
301.907.6977
